Literature DB >> 20476738

Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-alpha,beta-didehydrophenylalanine (Delta(Z)Phe) residues.

Domenica Torino1, Adriano Mollica, Francesco Pinnen, Federica Feliciani, Gino Lucente, Giancarlo Fabrizi, Gustavo Portalone, Peg Davis, Josephine Lai, Shou-Wu Ma, Frank Porreca, Victor J Hruby.   

Abstract

New endomorphin-2 (EM-2) analogues incorporating (Z)-alpha,beta-didehydrophenylalanine (Delta(Z)Phe) in place of the native phenylalanine in EM-2 are reported. Tyr-Pro-Delta(Z)Phe-Phe-NH(2) {[Delta(Z)Phe(3)]EM-2} (1), Tyr-Pro-Phe-Delta(Z)Phe-NH(2) {[Delta(Z)Phe(4)]EM-2} (2), and Tyr-Pro-Delta(Z)Phe-Delta(Z)Phe-NH(2) {[Delta(Z)Phe(3,4)]EM-2}(3) have been synthesized, their opioid receptor binding affinities and tissue bioassay activities were determined, and their conformational properties were examined. Compound 2 shows high mu opioid receptor selectivity and mu agonist activity comparable to those of the native peptide. The conformation adopted in solution and in the crystal by N-Boc-Tyr-Pro-Delta(Z)Phe-Phe-NH(2) (8) is reported.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20476738      PMCID: PMC2918392          DOI: 10.1021/jm1001343

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  29 in total

1.  ACTH: a short introductory review.

Authors:  R Schwyzer
Journal:  Ann N Y Acad Sci       Date:  1977-10-28       Impact factor: 5.691

2.  Synthesis and evaluation of new endomorphin analogues modified at the Pro(2) residue.

Authors:  Domenica Torino; Adriano Mollica; Francesco Pinnen; Gino Lucente; Federica Feliciani; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2009-06-06       Impact factor: 2.823

Review 3.  Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations.

Authors:  V J Hruby; F al-Obeidi; W Kazmierski
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

4.  Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance.

Authors:  Giuliana Cardillo; Luca Gentilucci; Ahmed R Qasem; Fabio Sgarzi; Santi Spampinato
Journal:  J Med Chem       Date:  2002-06-06       Impact factor: 7.446

5.  Synthesis and binding activity of endomorphin-1 analogues containing beta-amino acids.

Authors:  G Cardillo; L Gentilucci; P Melchiorre; S Spampinato
Journal:  Bioorg Med Chem Lett       Date:  2000-12-18       Impact factor: 2.823

6.  Pronociceptive actions of dynorphin maintain chronic neuropathic pain.

Authors:  Z Wang; L R Gardell; M H Ossipov; T W Vanderah; M B Brennan; U Hochgeschwender; V J Hruby; T P Malan; J Lai; F Porreca
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

7.  The structure of an endomorphin analogue incorporating 1-aminocyclohexane-1-carboxlylic acid for proline is similar to the beta-turn of Leu-enkephalin.

Authors:  Mitsunobu Doi; Akiko Asano; Eri Komura; Yoko Ueda
Journal:  Biochem Biophys Res Commun       Date:  2002-09-13       Impact factor: 3.575

8.  Structure-activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues.

Authors:  Csaba Tömböly; Katalin E Kövér; Antal Péter; Dirk Tourwé; Dauren Biyashev; Sándor Benyhe; Anna Borsodi; Mahmoud Al-Khrasani; András Z Rónai; Géza Tóth
Journal:  J Med Chem       Date:  2004-01-29       Impact factor: 7.446

9.  New endomorphin analogues containing alicyclic beta-amino acids: influence on bioactive conformation and pharmacological profile.

Authors:  Attila Keresztes; Mária Szucs; Attila Borics; Katalin E Kövér; Eniko Forró; Ferenc Fülöp; Csaba Tömböly; Antal Péter; Annamária Páhi; Gabriella Fábián; Mariann Murányi; Géza Tóth
Journal:  J Med Chem       Date:  2008-06-24       Impact factor: 7.446

10.  Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2.

Authors:  Renata Perlikowska; Katarzyna Gach; Jakub Fichna; Geza Toth; Bogdan Walkowiak; Jean-Claude do-Rego; Anna Janecka
Journal:  Bioorg Med Chem       Date:  2009-05-03       Impact factor: 3.641

View more
  6 in total

1.  Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues.

Authors:  Giordano Lesma; Severo Salvadori; Francesco Airaghi; Engin Bojnik; Anna Borsodi; Teresa Recca; Alessandro Sacchetti; Gianfranco Balboni; Alessandra Silvani
Journal:  Mol Divers       Date:  2012-11-04       Impact factor: 2.943

Review 2.  Engineering endomorphin drugs: state of the art.

Authors:  Lawrence H Lazarus; Yoshio Okada
Journal:  Expert Opin Ther Pat       Date:  2012-01-04       Impact factor: 6.674

3.  The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues.

Authors:  Adriano Mollica; Francesco Pinnen; Azzurra Stefanucci; Federica Feliciani; Cristina Campestre; Luisa Mannina; Anatoly P Sobolev; Gino Lucente; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2012-03-22       Impact factor: 7.446

4.  Structural and biological exploration of phe(3)-phe(4)-modified endomorphin-2 peptidomimetics.

Authors:  Giordano Lesma; Severo Salvadori; Francesco Airaghi; Thomas F Murray; Teresa Recca; Alessandro Sacchetti; Gianfranco Balboni; Alessandra Silvani
Journal:  ACS Med Chem Lett       Date:  2013-07-11       Impact factor: 4.345

Review 5.  Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery.

Authors:  Yeon Sun Lee
Journal:  Biomolecules       Date:  2022-09-05

6.  Antimicrobial peptides.

Authors:  Ali Adem Bahar; Dacheng Ren
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.